Download PDF
Endoskopie heute 2011; 24(4): 222-228
DOI: 10.1055/s-0031-1283854
Originalarbeit
© Georg Thieme Verlag KG Stuttgart · New York

Stellenwert der Pathohistologie bei der Diagnostik von chronisch-entzündlichen Darmerkrankungen

Value of Pathohistology in Diagnostics of Chronic-Inflammatory Bowel Diseases
M. Vieth
1   Institut für Pathologie, Klinikum Bayreuth, 95445 Bayreuth
,
C. Langner
2   Institut für Pathologie, Medizinische Universität Graz, Graz, Österreich
,
H. Neumann
3   Medizinische Klinik I, Universität Erlangen-Nürnberg, 91054 Erlangen
› Author Affiliations
Further Information

Publication History

Publication Date:
21 December 2011 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die 3 häufigsten Formen der Kolitis sind die Infektion und die beiden chronisch entzündlichen Darmerkrankungen Colitis ulcerosa und Morbus Crohn. Eine histologische Unterscheidung ist möglich, wenn auch zuweilen schwierig. Ganz entscheidend sind hierbei die klinischen Angaben. Noch schwieriger ist die Unterscheidung zwischen sporadischen Adenomen und Kolitis-assoziierten Neoplasien. Es sind zwar relativ wenige Fälle, aber eine Unterscheidung ist natürlich klinisch wichtig, um das weitere Prozedere zu planen.

Molekulare Marker können bei der Differenzialdiagnose helfen, aber im Einzelfall auch unbrauchbar sein, sodass immer noch der Goldstandard des erfahrenen Pathologen mittels der Routine HE-Färbung gilt.

Abstract

The most 3 common forms of colitis are infectious colitis, ulcerative colitis and Crohn’s disease. The histological distinction is possible but can be difficult. Important are the clinical data. Even more difficult is the distinction of sporadic adenoma and colitis-associated neoplasia. Such cases are not frequent but distinction is important as further clinical procedures needs to be planned.

Molecular markers can help for differential diagnosis. Taken down to a single case such markers may be not useful at all. Goldstandard is still the experienced pathologist with diagnosis on routine H & E sections.

Schlüsselwörter

Kolitis - Colitis ulcerosa - Morbus Crohn - Histologie - Adenom - Infektion

Key words

colitis - ulcerative colitis - Crohn’s disease - histology - adenoma - infection
 

  • Literatur

  • 1 Borchard F. Differential diagnosis of colitis. Verh Dtsch Ges Pathol 1999; 83: 110-121
    PubMedGoogle Scholar
  • 2 Dejaco C, Oesterreicher C, Angelberger S et al. Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis. Endoscopy 2003; 35: 1004-1008
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Oberhuber G, Püspök A, Peck-Radosavlevic M et al. Aberrant esophageal HLA-DR expression in a high percentage of patients with Crohn’s disease. Am J Surg Pathol 1999; 23: 970-976
    CrossrefPubMedGoogle Scholar
  • 4 D’Haens G, Geboes K, Peeters M et al. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. Am J Gastroenterol 1997; 92: 1275-1279
    PubMedGoogle Scholar
  • 5 Ierardi E, Giorgio F, Zotti M et al. Infliximab therapy downregulation of basic fibroblast growth factor / syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis. J Clin Pathol 2011; 64: 968-972
    CrossrefPubMedGoogle Scholar
  • 6 Dignass A, Preiss JC, Aust DE et al. Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 − Ergebnisse einer Evidenzbasierten Konsensuskonferenz; AWMF-Registriernummer: 021 / 009. Z Gastroenterol 2011; 49: 1276-1341
    PubMedGoogle Scholar
  • 7 Manning AP, Bulgim OR, Dixon MF et al. Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut 1987; 28: 1489-1494
    CrossrefPubMedGoogle Scholar
  • 8 Borchard F. Formen und Nomenklatur der gastrointestinalen Epithelexpansion: Was ist Invasion?. Verh Dtsch Ges Pathol 2000; 84: 50-61
    PubMedGoogle Scholar
  • 9 Lim CH, Dixon MF, Vail A et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 2003; 52: 1127-1132
    CrossrefPubMedGoogle Scholar
  • 10 Watanabe K, Sogawa M, Yamagami H et al. Endoscopic differential diagnosis between ulcerative colitis-associated neoplasia and sporadic neoplasia in surveillance colonoscopy using narrow band imaging. Dig Endosc 2011; 23 (Suppl. 01) 143-149
    CrossrefPubMedGoogle Scholar
  • 11 Kudo S, Lambert R, Allen JI et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 2008; 68 (Suppl. 04) 3-47
    PubMedGoogle Scholar
  • 12 Lambert R, Kudo SE, Vieth M et al. Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc 2009; 70: 1182-1199
    CrossrefPubMedGoogle Scholar
  • 13 Schneider A, Stolte M. Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis. Z Gastroenterol 1993; 31: 192-197
    PubMedGoogle Scholar
  • 14 Lyda MH, Noffsinger A, Belli J et al. Multifocal neoplasia involving the colon and appendix in ulcerative colitis: pathological and molecular features. Gastroenterology 1998; 115: 1566-1573
    CrossrefPubMedGoogle Scholar
  • 15 Mikami T, Mitomi H, Hara A et al. Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms. Cancer 2000; 89: 733-740
    CrossrefPubMedGoogle Scholar
  • 16 Aust DE, Terdiman JP, Willenbucher RF et al. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers. Mod Pathol 2001; 14: 29-39
    CrossrefPubMedGoogle Scholar
  • 17 Aust DE, Terdiman JP, Willenbucher RF et al. The APC / beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer 2002; 94: 1421-1427
    CrossrefPubMedGoogle Scholar
  • 18 Leedham SJ, Graham TA, Oukrif D et al. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. Gastroenterology 2009; 136: 542.e6-550.e6
    PubMedGoogle Scholar
  • 19 Vieth M, Behrens H, Stolte M. Die schwierige Differenzialdiagnose der sporadischen Adenome und kolitisassoziierten intraepithelialen Neoplasien bei Colitis ulcerosa. Pathologe 2003; 24: 36-43
    PubMedGoogle Scholar
  • 20 Vieth M, Behrens H, Stolte M. Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut 2006; 55: 1151-1155
    CrossrefPubMedGoogle Scholar
  • 21 Mönkemüller K, Neumann H, Malfertheiner P et al. Advanced colon polypectomy. Clin Gastroenterol Hepatol 2009; 7: 641-652
    CrossrefPubMedGoogle Scholar
  • 22 Kashida H, Kudo SE. Early colorectal cancer: concept, diagnosis, and management. Int J Clin Oncol 2006; 11: 1-8
    CrossrefPubMedGoogle Scholar
  • 23 Mueller E, Vieth M, Stolte M et al. The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. Hum Pathol 1999; 30: 898-905
    CrossrefPubMedGoogle Scholar
  • 24 Sato A, MacHinami R. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma. Pathol Int 1999; 49: 858-868
    CrossrefPubMedGoogle Scholar
  • 25 Odze RD, Brown CA, Hartmann CJ et al. Genetic alterations in chronic ulcerative colitis-associated adenoma-like DALMs are similar to non-colitic sporadic adenomas. Am J Surg Pathol 2000; 24: 1209-1216
    CrossrefPubMedGoogle Scholar
  • 26 Wong NA, Mayer NJ, Anderson CE et al. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms. Hum Pathol 2003; 34: 580-588
    CrossrefPubMedGoogle Scholar
  • 27 Fogt F, Vortmeyer AO, Stolte M et al. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas. Hum Pathol 1998; 29: 961-964
    CrossrefPubMedGoogle Scholar
  • 28 Loddenkemper C. Diagnostic standards in the pathology of inflammatory bowel disease. Dig Dis 2009; 27: 576-583
    CrossrefPubMedGoogle Scholar
  • 29 Andersen SN, Rognum TO, Bakka A et al. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis. Mol Pathol 1998; 51: 327-332
    PubMedGoogle Scholar